Zhengye Biotechnology
ZYBT | NASDAQ
$1.43
-$0.07 (-4.67%)
At close: Nov 16, 2026, 4:00 PM ET
$1.43
$0.00 (0.00%)
After-hours:
Nov 16, 2026, 7:02 PM ET
Zhengye Biotechnology Company Profile
Company profile explainedCompany Profile
Zhengye Biotechnology Holding Limited specializes in the creation, manufacturing, and commercialization of animal health immunizations. The company primarily supplies the Chinese agricultural sector with vaccines tailored for a broad spectrum of farm animals, including swine, bovines, goats, ovines, and poultry. Additionally, its product range encompasses inoculations for canines. Beyond its domestic reach, the firm also distributes its offerings to international markets, notably exporting to Vietnam, Pakistan, and Egypt. Established in 2004, this enterprise bases its principal operations in Jilin, China, and operates as a subsidiary entity of Securingium Holding Limited.
Key Executives
| Name | Position |
|---|---|
| Aiden Han | Co-Chief Executive Officer |
| Songlin Song | Co-Chief Executive Officer |
| Ping Wang | Chief Financial Officer |
| Zhongyao Liu | Chief Operating Officer |
| Yuhong Cheng | Vice General Manager |
Zhengye Biotechnology
| Country | China |
| IPO Date | Jan 7, 2025 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 269 |
| CEO | Songlin Song |
Stock Details
| Ticker Symbol | ZYBT |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001975641 |
| CUSIP Number | G989MS101 |
| ISIN Number | KYG989MS1016 |
| SIC Code | 2834 |
Add to Watchlist
Select watchlists to add or remove ZYBT